Hypervascular liver lesions in radiologically normal liver

• Autor(a) principal: Souza, Dyego Leandro Bezerra de
• Data de Publicação: 2017
• Outros Autores: Amico, Enio Campos, Alves, José Roberto, Salviano, Fellipe Alexandre Macena, João, Samir Assi
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFRN
• Texto Completo: https://repositorio.ufrn.br/handle/123456789/54987; https://doi.org/10.1590/0102-6720201700010007
• topic: diagnosis; liver neoplasms; focal nodular hyperplasia; adenoma; liver cell neoplasm; metastasis; diagnóstico; metástase; neoplasias hepáticas; hiperplasia nodular focal; adenoma hepático

Background: The hypervascular liver lesions represent a diagnostic challenge. Aim: To identify risk factors for cancer in patients with non-hemangiomatous hypervascular hepatic lesions in radiologically normal liver. Method: This prospective study included patients with hypervascular liver lesions in radiologically normal liver. The diagnosis was made by biopsy or was presumed on the basis of radiologic stability in follow-up period of one year. Cirrhosis or patients with typical imaging characteristics of haemangioma were excluded. Results: Eightyeight patients were included. The average age was 42.4. The lesions were unique and were between 2-5 cm in size in most cases. Liver biopsy was performed in approximately 1/3 of cases. The lesions were benign or most likely benign in 81.8%, while cancer was diagnosed in 12.5% of cases. Univariate analysis showed that age >45 years (p< 0.001), personal history of cancer (p=0.020), presence of >3 nodules (p=0.003) and elevated alkaline phosphatase (p=0.013) were significant risk factors for cancer. Conclusion: It is safe to observe hypervascular liver lesions in normal liver in patients up to 45 years, normal alanine aminotransaminase, up to three nodules and no personal history of cancer. Lesion biopsies are safe in patients with atypical lesions and define the treatment to be established for most of these patients